Agfa Gevaert : Share buyback program – regulated information

Within the framework of the share buyback program which was announced in the press release of March 10, 2021, Agfa-Gevaert NV proceeded with the purchase of own shares on the market of Euronext Brussels.

The authorization to acquire own shares was granted to the Board of Directors by the Extraordinary General Meeting of Shareholders of May 12, 2020.

Agfa-Gevaert NV has requested a financial intermediary to repurchase Agfa-Gevaert shares for a maximum amount of 50,000,000 Euro on its behalf under the terms of an initial discretionary mandate agreement with validity until March 31, 2022, effective as from April 1, 2021.

As a result of a decision of the Board of Directors, the company, by notarial deed dated June 22, 2021, cancelled a total of 1,996,884 treasury shares.
This decision was taken in accordance with the authorization granted to the Board of Directors by the Extraordinary General Meeting of Shareholders on May 12, 2020. As a consequence, the new number of outstanding shares (denominator) is now 165,754,306.

On September 17, 2021, the Agfa-Gevaert Group held 2,707,089 own shares, which represents 1.63% of the total number of shares of the Group.

Detailed operations per day:

Date	Number of shares	Average price (€)	Minimum price (€)	Maximum price (€)	Total price (€)
September 13, 2021	40,938	4.2317	4.1900	4.2700	173,237.33
September 14, 2021	31,349	4.1718	4.1500	4.1950	130,781.76
September 15, 2021	46,947	4.1446	4.1300	4.1600	194,576.54
September 16, 2021	44,064	4.1402	4.1100	4.1600	182,433.77
September 17, 2021	38,155	4.1100	4.0750	4.1550	156,817.05
Total	201,453	4.1590	837,846.45

Since the beginning of the share buyback program until September 17^th, 2021; the Agfa-Gevaert Group bought 4,703,973 own shares, representing 2.80% of the total outstanding shares on April 1, 2021.

About Agfa

The Agfa-Gevaert Group is a leading company in imaging technology and IT solutions with over 150 years of experience. The Group holds four divisions: Radiology Solutions, HealthCare IT, Digital Print & Chemicals and Offset Solutions. They develop, manufacture and market analogue and digital systems for the healthcare sector, for specific industrial applications and for the printing industry. In 2020, the Group realized a turnover of 1,709 million Euro.

Contact:

Viviane Dictus

Director Corporate Communication
T [phone]
E [e-mail]

Johan Jacobs

Corporate Press Relations Manager
T [phone]
E [e-mail]